Mecomed to bolster region’s healthcare delivery through collaborative efforts in Medical Technology

The association is committed to working closely with MedTech industry leaders and decision-makers to enhance the use of the most innovative and safest medical technology for better patient outcomes.

Dubai, UAE, February 7, 2022 – Mecomed, the Medical Technology Association in the Middle East and Africa, hosted the Networking Breakfast at Arab Health 2022, one of the region’s leading medical technology events that took place last month at the Dubai World Trade Centre.

The event was attended by over 60 MedTech executives and government officials, wherein Rami Rajab, Chairman of Mecomed, highlighted the association’s achievements and shared strategic objectives in the post-pandemic era with the audience. He stated, “To improve the region’s healthcare experience, the industry must collaborate with the regulators on implementing the newest and safest medical technology. The challenges presented by the pandemic have inspired us to further improve patients’ health through innovations that will empower them to take better control of their wellbeing. Mecomed is committed to helping the MedTech industry flourish through efforts that impact policies, incorporate best world practices, and underline the true value of today’s medical technology.”

After the Chairman’s address, he moderated a panel discussion between Marwan Abdulaziz Al Janahi, Managing Director of Dubai Science Park, Tarek El-Rahbani, Senior Managing Director, Growth Emerging Markets (GEM-South), Boston Scientific, and Maher Abouzeid, CEO of MedServ Medical Investments, where the panellists discussed how the MedTech industry leads the transformation of healthcare in the Middle East and Africa, as part of its ongoing efforts to maintain stability and growth in the region’s healthcare systems while putting patients first. This event built on Mecomed’s efforts to establish higher-quality healthcare standards for the region by collaborating closely with private and public organizations, decision-makers, and HCPs.

Furthermore, Mecomed underlined the importance of partnerships between the MedTech industry and policymakers focused on enhancing the healthcare experience in the MEA region, enabled by the recent challenges of the pandemic. The association has continued to support countries in the region to build capabilities and educate stakeholders on the use of the most innovative technologies, including AI, remote monitoring devices, robotic surgeries, rapid testing, genomic sequencing, and others. Additionally, the accelerated digital evolution of medical devices has developed new challenges, requiring updated regulations and better market access to save time and improve the quality of care for patients through value-based healthcare.